Nationally Recognized Infectious Disease Experts Will Discuss and Encourage Flu Vaccination During the Pandemic

Global Healthy Living Foundation to Host Live Webinar on October 27 UPPER NYACK, N.Y.–(BUSINESS WIRE)–#arthritis–The Global Healthy Living Foundation (GHLF), a patient-centered non-profit organization whose mission is to improve the quality of life for people with chronic illness, will host a live, 1-hour webinar on October 27 at 5pm EDT titled, “The Flu Vaccine and … [Read more…]

Global Dendritic Cell Cancer Vaccine Immunotherapy Market (2020 to 2026) – Dosage, Price & Clinical Trials Insight –

DUBLIN–(BUSINESS WIRE)–The “Global Dendritic Cell Cancer Vaccine Immunotherapy Market, Dosage, Price & Clinical Trials Insight 2026” report has been added to’s offering. In the past few years, significant breakthroughs in the medical research have led to the opening of novel doors to harness the immune system of the body against the cancer cells. For … [Read more…]

FARXIGA DAPA-CKD Phase III Trial Reduced Worsening of Kidney Function, Risk of Cardiovascular or Renal Death in Patients With Chronic Kidney Disease Irrespective of Underlying Cause

Results reinforce FARXIGA’s potential to treat a wide range of patients with chronic kidney disease WILMINGTON, Del.–(BUSINESS WIRE)–A new subgroup analysis from the ground-breaking DAPA-CKD Phase III trial showed that AstraZeneca’s FARXIGA® (dapagliflozin), on top of standard of care, reduced the composite of worsening of kidney function or risk of cardiovascular (CV) or renal death … [Read more…]

Home Healthcare Market by Product, Service, Indication, and Region – Global Forecast to 2025 –

DUBLIN–(BUSINESS WIRE)–The “Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Monitors, Nebulizers, BP Monitors), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication, Region – Global Forecast to 2025” report has been added to’s offering. The global home healthcare market is projected to reach USD 274.73 billion by 2025 from USD 181.92 … [Read more…]

Bayer’s FIDELIO-DKD Phase III Study Demonstrated Investigational Drug Finerenone Significantly Reduced Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes

Finerenone is a potential first-in-class investigational, non-steroidal, selective mineralocorticoid receptor antagonist (MRA) that works on the pathway of MR overactivation, a key contributor to disease progression in patients with chronic kidney disease and type 2 diabetes FIDELIO-DKD is the first large contemporary positive outcomes study in patients with chronic kidney disease and type 2 diabetes … [Read more…]

Worldwide Fetal and Neonatal Monitoring Devices Industry to 2025 – Maternal Complications and Advanced Maternal Age are Driving the Market –

DUBLIN–(BUSINESS WIRE)–The “Global Fetal and Neonatal Monitoring Devices Market” report has been added to’s offering. The global market for fetal and neonatal monitors should grow from $4.8 billion in 2020 to $6.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025. Fetal ultrasound market as a … [Read more…]

Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

Synairgen’s SNG001 among the many potential treatments and vaccines to be delivered via Aerogen’s aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively treated with Aerogen’s Solo aerosol drug delivery system in the intensive care unit 1 Aerogen technology is featured in guidelines and papers on the treatment of … [Read more…]

Gilead Sciences Completes Acquisition of Immunomedics, Inc.

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate. “We are very pleased to reach today’s milestone and to welcome the talented Immunomedics team to the Gilead family. There is a lot of important … [Read more…]

Remote Medical International Partners With to Provide COVID-19 Saliva Tests That Can Be Administered From Anywhere

Onsite Workforce Provider to Offer Easy and Convenient Solutions for Customers Stationed Remotely, from Pipeline Installations to Film Production Sites SAN FRANCISCO–(BUSINESS WIRE)–Remote Medical International, the company providing workplace health and safety services for Fortune 100 corporations, today announced it has partnered with, the leading testing as a service (TaaS) company, to deliver saliva-based … [Read more…]

Medical Devices Market | COVID-19 Recovery Analysis, Drivers, Restraints, Opportunities and Threats | Technavio

LONDON–(BUSINESS WIRE)–#GlobalMedicalDevicesMarket–The medical devices market is poised to grow by USD 87.65 billion during 2020-2024 progressing at a CAGR of almost 4% during the forecast period. The report on the medical devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an … [Read more…]